These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 2706326)

  • 41. The prognostic significance of determining DNA content in breast cancer by DNA image cytometry: the role of high grade aneuploidy in node negative breast cancer.
    Yildirim-Assaf S; Coumbos A; Hopfenmüller W; Foss HD; Stein H; Kühn W
    J Clin Pathol; 2007 Jun; 60(6):649-55. PubMed ID: 17557867
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cytosol protein content and prognosis in operable breast cancer. Correlations with steroid hormone receptors and other prognostic factors.
    Søreide JA; Lea OA; Kvinnsland S
    Breast Cancer Res Treat; 1991 Dec; 20(1):25-32. PubMed ID: 1813067
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The correlation between estrogen receptor status, axillary-node metastases and disease-free interval after surgery in primary breast cancer.
    Caldarola L; Calderini P; Volterrani P; Di Carlo F; Gaglia P
    Ital J Surg Sci; 1983; 13(3):179-85. PubMed ID: 6643007
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Flow cytophotometry parameters, hormone receptors and axillary lymph node status as prognostic factors in primary breast cancer].
    Kaufmann M; Feichter GE; Nhila A; Klinga K; Abel U
    Geburtshilfe Frauenheilkd; 1988 Oct; 48(10):705-9. PubMed ID: 3234702
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reappraisal of internal mammary node metastases as a prognostic factor in patients with breast cancer.
    Noguchi M; Ohta N; Koyasaki N; Taniya T; Miyazaki I; Mizukami Y
    Cancer; 1991 Nov; 68(9):1918-25. PubMed ID: 1655229
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prognostic value of quantitative cytometry in a series of 415 T1T2/N0N1/M0 breast cancer patients--preliminary results.
    Bolla M; Seigneurin D; Winckel P; Marron-Charrière J; Panh MH; Pasquier D; Ch-edin M; Payan R; Merlin F; Colonna M
    Eur J Cancer; 1996 Sep; 32A(10):1680-5. PubMed ID: 8983274
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multivariate analysis of DNA ploidy, p53, c-erbB-2 proteins, EGFR, and steroid hormone receptors for prediction of poor short term prognosis in breast cancer.
    Eissa S; Khalifa A; el-Gharib A; Salah N; Mohamed MK
    Anticancer Res; 1997; 17(2B):1417-23. PubMed ID: 9137508
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic value of cytosolic p53 protein in breast cancer.
    Montero S; Guzmán C; Vargas C; Ballestín C; Cortés-Funes H; Colomer R
    Tumour Biol; 2001; 22(5):337-44. PubMed ID: 11553865
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Estrogen receptors in primary breast cancer.
    Neifeld JP; Lawrence W; Brown PW; Banks WL; Terz JJ
    Arch Surg; 1982 Jun; 117(6):753-7. PubMed ID: 7082164
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prediction of relapse and survival in breast cancer patients by pS2 protein status.
    Foekens JA; Rio MC; Seguin P; van Putten WL; Fauque J; Nap M; Klijn JG; Chambon P
    Cancer Res; 1990 Jul; 50(13):3832-7. PubMed ID: 2354435
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic significance of c-erbB-2 and estrogen receptor status in human breast cancer.
    McCann AH; Dervan PA; O'Regan M; Codd MB; Gullick WJ; Tobin BM; Carney DN
    Cancer Res; 1991 Jun; 51(12):3296-303. PubMed ID: 1674898
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Estrogen receptor protein of breast cancer in patients with positive nodes. High recurrence rates in the postmenopausal estrogen receptor-negative group.
    Kinne DW; Butler JA; Kimmel M; Flehinger BJ; Menendez-Botet C; Schwartz M
    Arch Surg; 1987 Nov; 122(11):1303-6. PubMed ID: 3675194
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tumor-infiltrating lymphocytes are significantly associated with better overall survival and disease-free survival in triple-negative but not estrogen receptor-positive breast cancers.
    Krishnamurti U; Wetherilt CS; Yang J; Peng L; Li X
    Hum Pathol; 2017 Jun; 64():7-12. PubMed ID: 28153508
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic significance of axillary nodal status in primary breast cancer in relation to the number of resected nodes. Stockholm Breast Cancer Study Group.
    Wilking N; Rutqvist LE; Carstensen J; Mattsson A; Skoog L
    Acta Oncol; 1992; 31(1):29-35. PubMed ID: 1586501
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prognostic value of cells with more than 5c DNA content in node-negative breast cancer as determined by image cytometry from tissue sections.
    Siitonen SM; Kallioniemi OP; Helin HJ; Isola JJ
    Hum Pathol; 1993 Dec; 24(12):1348-53. PubMed ID: 8276382
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Evidence-based radiotherapy in the treatment of early-stage invasive breast cancer: traditional clinical features and biomarkers].
    Fodor J
    Magy Onkol; 2009 Mar; 53(1):7-14. PubMed ID: 19318321
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic value of steroid hormone receptors: multivariate analysis of systemically untreated patients with node negative primary breast cancer.
    Thorpe SM; Rose C; Rasmussen BB; Mouridsen HT; Bayer T; Keiding N
    Cancer Res; 1987 Nov; 47(22):6126-33. PubMed ID: 3664512
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Epithelial growth factor receptors (EGF-R) and DNA flow cytometry in addition to lymph node and hormone receptor status as prognostic factors in primary breast cancer].
    Costa SD; Kaufmann M; Fabbro D; Tokus M; Feichter G; Klinga K; Bastert G
    Geburtshilfe Frauenheilkd; 1989 Apr; 49(4):375-8. PubMed ID: 2544476
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Proportional hazards and recursive partitioning and amalgamation analyses of the Southwest Oncology Group node-positive adjuvant CMFVP breast cancer data base: a pilot study.
    Albain KS; Green S; LeBlanc M; Rivkin S; O'Sullivan J; Osborne CK
    Breast Cancer Res Treat; 1992; 22(3):273-84. PubMed ID: 1391993
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Correlation between c-erbB-2 amplification and risk of recurrent disease in node-negative breast cancer.
    Paterson MC; Dietrich KD; Danyluk J; Paterson AH; Lees AW; Jamil N; Hanson J; Jenkins H; Krause BE; McBlain WA
    Cancer Res; 1991 Jan; 51(2):556-67. PubMed ID: 1670762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.